Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review
Journal of Scleroderma and Related Disorders · 2025-10 · 10 (3) · 251-266
DOI: 10.1177/23971983241308050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Scleroderma and Related Disorders, online erschienen am 08.01.2025. Verfasst von Sandra Cuevas und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Puerto Rico School of Medicine, San Juan, Puerto Rico. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, Jerome L. Greene Foundation.
Abstract (Originalsprache)
Autonomic dysfunction is a common and early complication among patients with systemic sclerosis, suggesting that it may play a role in the pathogenesis of the disease and be a potential target for therapeutic interventions. Although the true prevalence of autonomic dysfunction among patients with systemic sclerosis is still unclear, it is estimated that as many as 80% of patients may be affected. Autonomic dysfunction may lead to widespread multi-organ dysfunction through its effects on the cardiovascular system, gastrointestinal tract, urinary tract, sweat and salivary glands, and pupils. Early identification of systemic sclerosis associated with dysautonomia may guide prompt diagnosis in this complex patient population and lay the groundwork for future research in this area. Furthermore, the current landscape of targeted interventions for autonomic dysfunction is rapidly expanding; therefore, prioritizing patients who may benefit from such interventions or candidates for related clinical trials is paramount. Our scoping review details timely updates in the extant literature, including findings from recent studies on autonomic dysfunction in systemic sclerosis, and integrates these updates to identify critical gaps in the field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Puerto Rico School of Medicine, San Juan, Puerto Rico.
- McMaster University, Hamilton, ON, Canada.
- Division of Musculoskeletal & Dermatological Sciences, The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK.
- Northern Care Alliance NHS Foundation Trust, Salford Care Organisation, Salford, UK.
- Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA.
- UTHealth Houston, Houston, TX, USA.
ORCID-Profile: Sandra Cuevas
Förderung
- NIAMS NIH HHS
- Jerome L. Greene Foundation
Zitieren
APA
Cuevas, S., Mayer, E., Hughes, M., Adler, B. L., & McMahan, Z. H. (2025). Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review. Journal of Scleroderma and Related Disorders, 10(3), 251-266. https://doi.org/10.1177/23971983241308050
Vancouver
Cuevas S, Mayer E, Hughes M, Adler BL, McMahan ZH. Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review. Journal of Scleroderma and Related Disorders. 2025;10(3):251-266. doi:10.1177/23971983241308050
BibTeX
@article{Cuevas2025,
author = {Cuevas, Sandra and Mayer, Erik and Hughes, Michael and Adler, Brittany L and McMahan, Zsuzsanna H},
title = {Evidence for targeting autonomic dysfunction in systemic sclerosis: A scoping review},
journal = {Journal of Scleroderma and Related Disorders},
year = {2025},
volume = {10},
number = {3},
pages = {251--266},
doi = {10.1177/23971983241308050}
}
EUVIMED